Cardiovascular Health Research has shown that certain GLP-1 medications may provide cardiovascular benefits for appropriate patients
To investigate this, ex vivo assessment of thoracic aorta sections from vehicle- and semaglutide-treated ZSF1 obese rats was performed
Other patients are resorting to even riskier options online where they can essentially diagnose themselves, said Dr
Since January 2026, prescribers can no longer rely on an online questionnaire alone and must verify their weight, height, and BMI
Timing does not meaningfully affect outcomes in the published trials
People with a history of certain thyroid cancers in themselves or family members, people with pancreatitis and people with gastrointestinal conditions, especially gastroparesis, should not take GLP-1s